Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Xiqing and Probiotics on Intestinal Homeostasis and Efficacy in CKD
NCT07182942Phase 4Recruiting
- Start
- Jun 2024
- Primary completion
- Nov 2025
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of aldehyde oxystarch in chronic kidney disease (CKD). Started Jun 2024; status: recruiting.
02
Drugs
aldehyde oxystarch
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07182942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07182942.